Capitolis Liquid Global Markets LLC Abbott Laboratories Transaction History
Capitolis Liquid Global Markets LLC
- $9.43 Trillion
- Q3 2024
A detailed history of Capitolis Liquid Global Markets LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Capitolis Liquid Global Markets LLC holds 500,000 shares of ABT stock, worth $57.1 Million. This represents 0.6% of its overall portfolio holdings.
Number of Shares
500,000
Previous 700,000
28.57%
Holding current value
$57.1 Million
Previous $72.7 Billion
21.63%
% of portfolio
0.6%
Previous 0.9%
Shares
2 transactions
Others Institutions Holding ABT
# of Institutions
3,186Shares Held
1.3BCall Options Held
8.74MPut Options Held
8.08M-
Vanguard Group Inc Valley Forge, PA168MShares$19.2 Billion0.35% of portfolio
-
Black Rock Inc. New York, NY131MShares$15 Billion0.31% of portfolio
-
State Street Corp Boston, MA76.7MShares$8.76 Billion0.36% of portfolio
-
Capital International Investors Los Angeles, CA65.7MShares$7.51 Billion1.49% of portfolio
-
Capital Research Global Investors Los Angeles, CA53.3MShares$6.09 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $200B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...